Product Added to Cart!
$208.90

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI03004_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-b-cyclohexyl-D-alanine
Brand Name
Chem Impex
Product Number
03004
CAS
144701-25-7
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
978327
IUPAC Name
(2R)-3-cyclohexyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
InChI Key
HIJAUEZBPWTKIV-JOCHJYFZSA-N
SMILES
C1CCC(CC1)CC@H(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Description

Fmoc-b-cyclohexyl-D-alanine is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, particularly in solid-phase peptide synthesis, allowing researchers to create complex and functional peptide sequences efficiently.

Drug Development: Its unique structural properties make it valuable in the design of peptide-based drugs, offering potential therapeutic applications in treating various diseases, including cancer and metabolic disorders.

Bioconjugation: The compound can be used in bioconjugation processes, where it helps attach peptides to other biomolecules, enhancing the specificity and efficacy of drug delivery systems.

Research in Neuroscience: Due to its ability to mimic natural amino acids, it is employed in studies exploring neuropeptide interactions, aiding in the understanding of neurological pathways and potential treatments for neurodegenerative diseases.

Material Science: Fmoc-b-cyclohexyl-D-alanine is also explored in the development of novel materials, such as hydrogels, which can be used in tissue engineering and regenerative medicine, providing scaffolds for cell growth.

References Data Source From Pubchem

In-solution enrichment identifies peptide inhibitors of protein–protein interactions

Publication Name: Nature Chemical Biology
Publication Date: 2019-03-18
DOI: 10.1038/s41589-019-0245-2

DR396, an apoptotic DNase γ inhibitor, attenuates high mobility group box 1 release from apoptotic cells

Publication Name: Bioorganic & Medicinal Chemistry
Publication Date: 2011-01-01
DOI: 10.1016/j.bmc.2010.11.037